Ruo Yu Chen

Ruo Yu Chen currently works at Continent Pharmaceutical, Inc., as Executive Director from 2018, Beijing Continent Pharmaceutical Co., Ltd., as Executive Director from 2018, GNI-EPS Pharmaceuticals, inc., as Supervisor, Cullgen, Inc., as Finance Controller, and Cullgen Shanghai, Inc., as Supervisor.
Ms. Chen also formerly worked at GNI Group Ltd., as Director-Finance & Accounting from 2014 to 2021, GNI USA, Inc., as Senior Vice President-Finance, Protiviti LLC, as Manager-Internal Audit Division from 2011 to 2014, and Gyre Therapeutics, Inc., as Chief Financial Officer from 2023 to 2026.
Ms. Chen received her undergraduate degree in 1992 from Nankai University and graduate degree from Graduate School of Economics Kyoto University.